WTC
APLS

WhitTier Trust Company’s Apellis Pharmaceuticals APLS Stock Holding History

WhitTier Trust Company’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-91
Closed -$2.62K – 1357
2024
Q3 		$2.62K Hold
91
– – ﹤0.01% 1199
2024
Q2 		$3.49K Buy
91
+31
+52% +$1.4K ﹤0.01% 1117
2024
Q1 		$3.53K Sell
60
-2
-3% -$127 ﹤0.01% 1076
2023
Q4 		$3.71K Hold
62
– – ﹤0.01% 1071
2023
Q3 		$2.36K Buy
62
+25
+68% +$1.1K ﹤0.01% 1065
2023
Q2 		$3.37K Sell
37
-1
-3% -$86 ﹤0.01% 1068
2023
Q1 		$2.51K Buy
+38
New +$2.19K ﹤0.01% 1070

Other funds holding APLS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

WhitTier Trust Company's APLS Position: Q4 2024 in Review

WhitTier Trust Company sold out of Apellis Pharmaceuticals (APLS) in Q4 2024, closing a stake of 91 shares — an estimated $2.62K sold.

WhitTier Trust Company first reported a position in APLS in Q1 2023 and held it in 7 quarters. The position peaked at $3.71K in Q4 2023. 260 funds tracked by Wall St. Rank hold APLS as of Q4 2024.

  • WhitTier Trust Company reported no remaining Apellis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • WhitTier Trust Company sold 91 Apellis Pharmaceuticals shares in Q4 2024, an estimated $2.62K.
  • WhitTier Trust Company first reported a position in Apellis Pharmaceuticals in Q1 2023 and held it in 7 quarters.
  • WhitTier Trust Company's Apellis Pharmaceuticals position peaked at $3.71K in Q4 2023.
  • 260 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2024.

Based on WhitTier Trust Company's 13F filing for Q4 2024, filed 11 Feb 2025.